Nalaganje...
Interferon-regulatory factor-1 (IRF1) regulates bevacizumab induced autophagy
PURPOSE: Antiangiogenic therapy is commonly being used for the treatment of glioblastoma. However, the benefits of angiogenesis inhibitors are typically transient and resistance often develops. Determining the mechanism of treatment failure of the VEGF monoclonal antibody bevacizumab for malignant g...
Shranjeno v:
izdano v: | Oncotarget |
---|---|
Main Authors: | , , , , |
Format: | Artigo |
Jezik: | Inglês |
Izdano: |
Impact Journals LLC
2015
|
Teme: | |
Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4741619/ https://ncbi.nlm.nih.gov/pubmed/26362401 |
Oznake: |
Označite
Brez oznak, prvi označite!
|